These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 19963237)

  • 21. The extent of lymphadenectomy seems to be associated with better survival in patients with nonmetastatic upper-tract urothelial carcinoma: how many lymph nodes should be removed?
    Roscigno M; Shariat SF; Margulis V; Karakiewicz P; Remzi M; Kikuchi E; Zigeuner R; Weizer A; Sagalowsky A; Bensalah K; Raman JD; Bolenz C; Kassou W; Koppie TM; Wood CG; Wheat J; Langner C; Ng CK; Capitanio U; Bertini R; Fernández MI; Mikami S; Isida M; Ströbel P; Montorsi F
    Eur Urol; 2009 Sep; 56(3):512-8. PubMed ID: 19559518
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transitional cell carcinomas of the renal pelvis and the ureter: comparative demographic characteristics, pathological grade and stage and 5-year survival in a Taiwanese population.
    Tan LB; Chang LL; Cheng KI; Huang CH; Kwan AL
    BJU Int; 2009 Feb; 103(3):312-6. PubMed ID: 18782312
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lymph node yield and tumor location in patients with upper tract urothelial carcinoma undergoing nephroureterectomy affects survival: A U.S. population-based analysis (2004-2012).
    Chappidi MR; Kates M; Johnson MH; Hahn NM; Bivalacqua TJ; Pierorazio PM
    Urol Oncol; 2016 Dec; 34(12):531.e15-531.e24. PubMed ID: 27476032
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of tumor necrosis with pathological features and clinical outcome in 754 patients undergoing radical nephroureterectomy for upper tract urothelial carcinoma: an international validation study.
    Seitz C; Gupta A; Shariat SF; Matsumoto K; Kassouf W; Walton TJ; Fritsche HM; Otto W; Tritschler S; Bastian PJ; Carballido J; Ficarra V; Karakiewicz PI; Artibani W; Mazzoleni G; Novara G
    J Urol; 2010 Nov; 184(5):1895-900. PubMed ID: 20846680
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Postoperative radiation therapy in 26 patients with invasive transitional cell carcinoma of the upper urinary tract: no impact on survival?
    Maulard-Durdux C; Dufour B; Hennequin C; Chrétien Y; Vignes B; Droz D; Delanian S; Housset M
    J Urol; 1996 Jan; 155(1):115-7. PubMed ID: 7490805
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Laparoscopic radical nephroureterectomy for upper tract transitional cell carcinoma: the Cleveland Clinic experience.
    Gill IS; Sung GT; Hobart MG; Savage SJ; Meraney AM; Schweizer DK; Klein EA; Novick AC
    J Urol; 2000 Nov; 164(5):1513-22. PubMed ID: 11025694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of the extent of regional lymphadenectomy on the survival of patients with urothelial carcinoma of the upper urinary tract.
    Kondo T; Nakazawa H; Ito F; Hashimoto Y; Toma H; Tanabe K
    J Urol; 2007 Oct; 178(4 Pt 1):1212-7; discussion 1217. PubMed ID: 17698147
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Laparoscopic radical nephroureterectomy: a multicenter analysis in Japan.
    Kamihira O; Hattori R; Yamaguchi A; Kawa G; Ogawa O; Habuchi T; Kawauchi A; Uozumi J; Yokoi S; Tsujihata M; Hasui Y; Miyakoda K; Tada H; Ono Y; Naito S
    Eur Urol; 2009 Jun; 55(6):1397-407. PubMed ID: 19299072
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endoscopic management of upper tract transitional cell carcinoma in patients with normal contralateral kidneys.
    Thompson RH; Krambeck AE; Lohse CM; Elliott DS; Patterson DE; Blute ML
    Urology; 2008 Apr; 71(4):713-7. PubMed ID: 18267338
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Laparoscopic nephroureterectomy for upper urinary tract transitional cell carcinoma: is it better than open surgery?
    Rassweiler JJ; Schulze M; Marrero R; Frede T; Palou Redorta J; Bassi P
    Eur Urol; 2004 Dec; 46(6):690-7. PubMed ID: 15548434
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Temporal stage and grade migration in surgically treated patients with upper tract urothelial carcinoma.
    Lughezzani G; Jeldres C; Isbarn H; Sun M; Shariat SF; Widmer H; Arjane P; Graefen M; Perrotte P; Montorsi F; Karakiewicz PI
    BJU Int; 2010 Mar; 105(6):799-804. PubMed ID: 19725824
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preoperative multivariable prognostic model for prediction of nonorgan confined urothelial carcinoma of the upper urinary tract.
    Margulis V; Youssef RF; Karakiewicz PI; Lotan Y; Wood CG; Zigeuner R; Kikuchi E; Weizer A; Raman JD; Remzi M; Roscigno M; Montorsi F; Bolenz C; Kassouf W; Shariat SF;
    J Urol; 2010 Aug; 184(2):453-8. PubMed ID: 20620397
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prognostic predictors of primary ureteral transitional cell carcinoma after radical nephroureterectomy.
    Li WM; Li CC; Ke HL; Wu WJ; Huang CN; Huang CH
    J Urol; 2009 Aug; 182(2):451-8; discussion 458. PubMed ID: 19524962
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of the minimum number of lymph nodes needed to detect lymph node invasion at radical nephroureterectomy in patients with upper tract urothelial cancer.
    Roscigno M; Shariat SF; Freschi M; Margulis V; Karakiewizc P; Suardi N; Remzi M; Zigeuner R; Bolenz C; Kikuchi E; Weizer A; Bensalah K; Sagalowsky A; Koppie TM; Raman J; Fernández M; Ströbel P; Kabbani W; Langner C; Wheat J; Guo CC; Kassouf W; Haitel A; Wood CG; Montorsi F
    Urology; 2009 Nov; 74(5):1070-4. PubMed ID: 19883824
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Long-term results of surgical treatment for renal pelvic and ureteral tumors].
    Yokoyama M; Kano M; Sakai M; Oda H; Inoue K; Kitahara K; Kanemura M; Osada M
    Hinyokika Kiyo; 1995 Oct; 41(10):761-6. PubMed ID: 8533670
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Urothelial cancer of the upper urinary tract].
    Jurincic-Winkler C; Horlbeck R; Gasser A; Glenewinkel J; Klippel KF
    Urologe A; 1993 Jul; 32(4):295-9. PubMed ID: 8372411
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oncologic outcomes and survival in pT0 tumors after radical nephroureterectomy for upper tract urothelial carcinoma: results from of a large multicenter international collaborative study.
    Rouprêt M; Xylinas E; Colin P; Kluth L; Karakiewicz P; Shariat SF
    Eur Urol; 2013 Feb; 63(2):404-5. PubMed ID: 23040206
    [No Abstract]   [Full Text] [Related]  

  • 38. A population based assessment of perioperative mortality after cystectomy for bladder cancer.
    Isbarn H; Jeldres C; Zini L; Perrotte P; Baillargeon-Gagne S; Capitanio U; Shariat SF; Arjane P; Saad F; McCormack M; Valiquette L; Peloquin F; Duclos A; Montorsi F; Graefen M; Karakiewicz PI
    J Urol; 2009 Jul; 182(1):70-7. PubMed ID: 19447427
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic value of lymphovascular invasion in transitional cell carcinoma of upper urinary tract.
    Hong B; Park S; Hong JH; Kim CS; Ro JY; Ahn H
    Urology; 2005 Apr; 65(4):692-6. PubMed ID: 15833510
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence-based sex-related outcomes after radical nephroureterectomy for upper tract urothelial carcinoma: results of large multicenter study.
    Fernández MI; Shariat SF; Margulis V; Bolenz C; Montorsi F; Suardi N; Remzi M; Wood CG; Roscigno M; Kikuchi E; Oya M; Zigeuner R; Langner C; Weizer A; Lotan Y; Koppie TM; Raman JD; Karakiewicz P; Bensalah K; Schultz M; Bernier P
    Urology; 2009 Jan; 73(1):142-6. PubMed ID: 18845322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.